Matches in SemOpenAlex for { <https://semopenalex.org/work/W2086404290> ?p ?o ?g. }
- W2086404290 endingPage "5949" @default.
- W2086404290 startingPage "5937" @default.
- W2086404290 abstract "An effective virus-like particle (VLP) based prophylactic vaccine designed to protect against persistent infection with human papillomavirus (HPV) types 16 and 18 and subsequent lesion development will need to induce a strong humoral and cellular immune response capable of providing long-term protection. Our objective was to evaluate the ability of an HPV16/18 L1 VLP vaccine formulated with the AS04 adjuvant system (3-O-desacyl-4'-monophosphoryl lipid A (MPL) and aluminium salt) to induce an immune response of higher magnitude and persistence compared to a vaccine formulated with aluminium salt only. We demonstrated that MPL adsorbed onto aluminium salt retains its capacity to activate an innate immune response as assessed by the production of TNFalpha by human monocytes (U937). In addition, vaccination of mice, monkeys or human subjects with AS04 formulations induced higher total anti-L1 VLP16 and L1 VLP18 antibody responses (1.6-8.5-fold) than the aluminium salt only formulations. The enhanced antibody response induced by the AS04 vaccine formulation (1.6-4.1-fold) in monkeys and humans was shown to be targeted to functional neutralising L1 VLP16 and L1 VLP18 epitopes as assessed by V5/J4 specific ELISAs or HPV16 and HPV18 pseudo-neutralization assays. The enhanced immune profile observed with the AS04 formulation in terms of both total, V5/J4 specific and neutralizing antibodies was shown to persist for at least 3.5-year post-vaccination in human subjects. Finally, using the newly developed B cell ELISPOT assay we also demonstrated that the AS04 formulation elicited an increased frequency (2.2-5.2-fold) of HPV L1 VLP specific memory B cells when compared with the aluminium salt only formulations. These data strongly support the role of the AS04 adjuvant, which includes the immunostimulant MPL, in triggering a persistent vaccine-induced immune response of high quality." @default.
- W2086404290 created "2016-06-24" @default.
- W2086404290 creator A5003127549 @default.
- W2086404290 creator A5011550497 @default.
- W2086404290 creator A5015174914 @default.
- W2086404290 creator A5015844833 @default.
- W2086404290 creator A5019152388 @default.
- W2086404290 creator A5026575333 @default.
- W2086404290 creator A5026909353 @default.
- W2086404290 creator A5028276022 @default.
- W2086404290 creator A5033423842 @default.
- W2086404290 creator A5062016488 @default.
- W2086404290 creator A5063326990 @default.
- W2086404290 creator A5070462448 @default.
- W2086404290 creator A5078934783 @default.
- W2086404290 date "2006-08-14" @default.
- W2086404290 modified "2023-10-14" @default.
- W2086404290 title "Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only" @default.
- W2086404290 cites W1483162601 @default.
- W2086404290 cites W1486683597 @default.
- W2086404290 cites W1489188497 @default.
- W2086404290 cites W1518785179 @default.
- W2086404290 cites W1525912444 @default.
- W2086404290 cites W1538962595 @default.
- W2086404290 cites W1591218587 @default.
- W2086404290 cites W1655860314 @default.
- W2086404290 cites W1820208462 @default.
- W2086404290 cites W1897355343 @default.
- W2086404290 cites W1957151625 @default.
- W2086404290 cites W1973153995 @default.
- W2086404290 cites W1981531030 @default.
- W2086404290 cites W1981726005 @default.
- W2086404290 cites W1987350137 @default.
- W2086404290 cites W1991810608 @default.
- W2086404290 cites W1995350271 @default.
- W2086404290 cites W2001429203 @default.
- W2086404290 cites W2001988677 @default.
- W2086404290 cites W2006924252 @default.
- W2086404290 cites W2007265276 @default.
- W2086404290 cites W2008564758 @default.
- W2086404290 cites W2019840235 @default.
- W2086404290 cites W2020830322 @default.
- W2086404290 cites W2023179470 @default.
- W2086404290 cites W2028492039 @default.
- W2086404290 cites W2040272072 @default.
- W2086404290 cites W2040348421 @default.
- W2086404290 cites W2049095033 @default.
- W2086404290 cites W2050871684 @default.
- W2086404290 cites W2050922850 @default.
- W2086404290 cites W2052550831 @default.
- W2086404290 cites W2067018191 @default.
- W2086404290 cites W2068204482 @default.
- W2086404290 cites W2071680164 @default.
- W2086404290 cites W2073678729 @default.
- W2086404290 cites W2079910321 @default.
- W2086404290 cites W2088457548 @default.
- W2086404290 cites W2088517066 @default.
- W2086404290 cites W2098491904 @default.
- W2086404290 cites W2098795075 @default.
- W2086404290 cites W2099660384 @default.
- W2086404290 cites W2100055887 @default.
- W2086404290 cites W2101196984 @default.
- W2086404290 cites W2105562430 @default.
- W2086404290 cites W2105667065 @default.
- W2086404290 cites W2110221887 @default.
- W2086404290 cites W2112859230 @default.
- W2086404290 cites W2112957913 @default.
- W2086404290 cites W2114813165 @default.
- W2086404290 cites W2115893060 @default.
- W2086404290 cites W2116458521 @default.
- W2086404290 cites W2118349945 @default.
- W2086404290 cites W2121335263 @default.
- W2086404290 cites W2121819501 @default.
- W2086404290 cites W2131967743 @default.
- W2086404290 cites W2135638164 @default.
- W2086404290 cites W2135674359 @default.
- W2086404290 cites W2138786372 @default.
- W2086404290 cites W2139349670 @default.
- W2086404290 cites W2145426305 @default.
- W2086404290 cites W2150383955 @default.
- W2086404290 cites W2150436558 @default.
- W2086404290 cites W2151365647 @default.
- W2086404290 cites W2151660552 @default.
- W2086404290 cites W2158172739 @default.
- W2086404290 cites W2158614517 @default.
- W2086404290 cites W2160874245 @default.
- W2086404290 cites W2162954621 @default.
- W2086404290 cites W2164173266 @default.
- W2086404290 cites W2170592973 @default.
- W2086404290 cites W2170736102 @default.
- W2086404290 cites W45195219 @default.
- W2086404290 cites W2414389174 @default.
- W2086404290 cites W3144581354 @default.
- W2086404290 doi "https://doi.org/10.1016/j.vaccine.2006.06.005" @default.
- W2086404290 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16828940" @default.
- W2086404290 hasPublicationYear "2006" @default.
- W2086404290 type Work @default.
- W2086404290 sameAs 2086404290 @default.